Avian influenza

Current Allergy and Asthma Reports

Volumn 6, Issue 2, 2006, Pages 163-170

  Zeitlin, Gary A ^b   Maslow, Melanie J ^a  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; OSELTAMIVIR; RIMANTADINE; SMALL INTERFERING RNA; STEROID; VIRUS VACCINE; ZANAMIVIR;

ANIMAL CARE; AVIAN INFLUENZA; DISINFECTION; DRUG FORMULATION; EARLY DIAGNOSIS; ECONOMICS; EPIDEMIC; GENE DELIVERY SYSTEM; GENETIC REASSORTMENT; HEALTH HAZARD; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MORBIDITY; MORTALITY; NONHUMAN; PLASMID; PUBLIC HEALTH; REVIEW; SOUTHEAST ASIA; THAILAND; VIET NAM; VIRUS STRAIN; ZOONOSIS;

ANIMALS; ASIA, SOUTHEASTERN; DISEASE OUTBREAKS; HUMANS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA, HUMAN; POULTRY;

EID: 33645797649     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-006-0055-y     Document Type: Review

References (35)

1. Meltzer ML, Con NJ, Fukuda K: The economic impact of pandemic influenza in the United States: priorities for intervention. Emerg Infect Dis 2001, 5:651-671.
2. Suarez DL: Evolution of avian influenza viruses. Vet Microbiol 2000, 74:15-27.
3. Kuiken T, Rimmelzwaan G, van Riel D, et al.: Avian H5N1 influenza in cats. Science 2004, 304:241.
4. Kurtz J, Manvell RI, Banks J: Avian influenza virus isolated from a woman with conjunctivitis. Lancet 1996, 348:901-902.
5. Yuen JY, Chan PK, Peiris M, et al.: Members of the H5N1 Study Group. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet 1998, 351:467-471.
6. Ludwig S, Stitz L, Planz O, et al.: European swine virus as a possible source of the next influenza pandemic? Virology 1995, 212:555-561.
7. Cauthen AN, Swayne DE, Schultz-Cherry S, et al.: Continued circulation in China of highly pathogenic avian influenza virus encoding the hemagglutinin gene associated with the 1997 H5N1 outbreak in poultry and humans. J Virol 2000, 74:6592-6599.
8. Bosman A, Meijer A, Koopmans M: Final analysis of Netherlands avian influenza outbreaks reveals much higher levels of transmission to humans than previously thought. Euro Surveill Wkly 2005, 10:1.
9. Guan ASL, Wang J, Smith GLD, et al.: Genesis of a highly pathogenic and potentially pandemic H5N1 influenza virus in eastern Asia. Nature 2003, 430:209-213.
10. Claas ECJ, Kawaoka Y, De Jong JC, et al.: Infection of children with avian-human reassortant influenza virus from pigs in Europe. Virology 1994, 204:453-457.
11. Hayden FG, Fritz R, Lobo MC, et al.: Local and systemic cytokine responses during experimental human influenza virus A infection: relation to symptom formation and host defense. J Clin Invest 1998, 101:643-649.
12. Peiris JSM, Yu WC, Leung CW, et al.: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet 2004, 363:617-619.
13. Cheung CY, Poon LLM, Lau AS, et al.: Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet 2002, 360:1831-1837.
14. Seo SH, Hoffmann E, Webster RG: Lethal H5N1 influenza viruses escape host anti-viral cytokine responses. Nat Med 2002, 8:950-954.
15. Guan Y, Poon LM, Cheung CY, et al.: H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A 2004, 101:8156-8161.
16. Hatta M, Gao P, Halfmann P, et al.: Molecular basis for high virulence of Hong Kong H5N1 influenza A viruses. Science 2001, 293:1840-1842.
17. Mastrosovich M, Mastrosovich T, Gray T, et al.: Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A 2004, 101:4620-4624.
18. Ito T, Goto H, Yamamoto E, et al.: Generation of a highly pathogenic influenza A virus from an avirulent field isolate by passaging in chickens. J Virol 2001, 79:4439-4443.
19. Chan PKS: Outbreak of avian influenza A (H5N1) in Hong Kong in 1997. Clin Infect Dis 2002, 34:S58-S64.
20. Kaye D, Pringle CR: Avian influenza viruses and their implications for human health. Clin Infect Dis 2005, 40:108-111.
21. Apisarnthanarak A, Kitphati R, Thongphubeth K, et al.: Atypical avian influenza (H5N1). Emerg Infect Dis 2004, 10:1321-1324.
22. Keawcharoen J, Oraveerakul K, Kuiken T, et al.: Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis 2004, 10:2189-2191.
23. Spackman E, Senne DA, Myers TJ: Development of a realtime reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes. J Clin Microbiol 2002, 40:3256-3260.
24. Shan S, Ko L, Collins RA, et al.: Comparison of nucleic acid-based detection of avian influenza H5N1 with virus isolation. Biochem Biophys Res Commun 2003, 302:377-383.
25. Stephenson I, Wood JM, Nicholson KG, et al.: Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. Virus Res 2004, 103:91-95.
26. Hoffmann E, Krauss S, Perez D, et al.: Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 2002, 20:3154.
27. Webby RJ, Webster RG: Are we ready for pandemic influenza? Science 2003, 302:1519-1522.
28. Smolinski MS, Hamburg MA, Lederberg J: Microbial Threats to Health: Emergence, Detection and Response. Washington, DC: Institute of Medicine of the National Academies, The National Academic Press; 2003.
29. Capua I, Marangon S: Vaccination for avian influenza in Asia. Vaccine 2004,22:4137-4138.
30. Normile D: Vaccinating birds may help to curtail virus's spread. Science 2004, 306:398-399.
31. Tran TH, Nguyen TL, Nguyen TD, et al.: Avian influenza A (H5N1) virus infection in 10 patients in Vietnam. N Engl J Med 2004, 350:1179-1188.
32. Cheng VSS, Tang BSF, Wu AKL, et al.: Medical treatment of viral pneumonia including SARS in the immunocompetent adult. J Infect 2004, 49:262-273.
33. Leneva IA, Goloubeva O, Fenton RJ, et al.: Efficacy of zanamavir against influenza A viruses that possess genes encoding H5N1 internal proteins and are pathogenic in mammals. Antimicrob Agents Chemother 2001, 45:1216-1224.
34. Leneva IA, Roberts N, Govorkova EA, et al.: The neuraminidase inhibitor GS1404 (oseltamavir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses. Antiviral Res 2000, 48:101-115.
35. Ge Q, Filip L, Bai A, et al.: Inhibition of influenza production in virus-infected mice by RNA interference. Proc Natl Acad Sci U S A 2004, 101:8676-8681.